Literature DB >> 32268980

Association of serum anti-Müllerian hormone and other factors with cumulative live birth rate following IVF.

Kai-Lun Hu1, Fen-Ting Liu2, Huiyu Xu3, Rong Li4, Jie Qiao3.   

Abstract

RESEARCH QUESTION: What are the optimal values of maternal age and body mass index (BMI), paternal age and BMI, number of oocytes retrieved, and serum AMH concentrations for cumulative live birth rate (CLBR) in IVF and embryo transfer (IVF-ET)?
DESIGN: This retrospective cohort study included 9494 women who underwent their first IVF-ET cycle between January 2017 and July 2018. The primary outcome was the CLBR within one complete cycle. Cox regression analysis was used to test the hazard ratio, with 95% confidence intervals.
RESULTS: CLBR was significantly lower when maternal age was over 35 (adjusted P < 0.01 for age 36-38 years, adjusted P < 0.00001 for all age groups above 38 years). CBLR increased with increasing serum AMH concentrations and number of retrieved oocytes up to peak values at 5-7 ng/ml AMH and 16-20 oocytes in all women. CLBR was significantly increased when serum AMH concentrations were 3-7 ng/ml (adjusted P < 0.001) and number of oocytes retrieved was more than five (adjusted P < 0.00001). Overweight had a negative effect on CLBR compared with normal BMI in women under 35 years of age (adjusted P = 0.037). In women aged over 35 years, paternal overweight had a negative effect on CLBR compared with normal paternal BMI (adjusted P < 0.01).
CONCLUSIONS: Maternal age had an impact on optimal serum AMH concentrations and number of oocytes retrieved. Maternal overweight negatively affected CLBR in women under 35 years of age, and paternal overweight negatively affected CLBR in women over 35 years.
Copyright © 2020 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anti-Müllerian hormone; Cumulative clinical live birth rate; IVF; Maternal age; Oocyte retrieval

Mesh:

Substances:

Year:  2020        PMID: 32268980     DOI: 10.1016/j.rbmo.2020.01.024

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  5 in total

Review 1.  Clinical Application of AMH Measurement in Assisted Reproduction.

Authors:  Hang Wun Raymond Li; Scott M Nelson
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-09       Impact factor: 5.555

2.  Blastocyst quality and perinatal outcomes in women undergoing single blastocyst transfer in frozen cycles.

Authors:  Kai-Lun Hu; Xiaoying Zheng; Sarah Hunt; Xiaohong Li; Rong Li; Ben W Mol
Journal:  Hum Reprod Open       Date:  2021-10-30

3.  Outcomes of in-vitro fertilization after bariatric surgery: a national register-based case-control study.

Authors:  E Nilsson-Condori; K Mattsson; A Thurin-Kjellberg; J L Hedenbro; B Friberg
Journal:  Hum Reprod       Date:  2022-09-30       Impact factor: 6.353

4.  The Combined Impact of Female and Male Body Mass Index on Cumulative Pregnancy Outcomes After the First Ovarian Stimulation.

Authors:  Zhonghua Zhao; Xue Jiang; Jing Li; Menghui Zhang; Jinhao Liu; Shanjun Dai; Hao Shi; Yuling Liang; Li Yang; Yihong Guo
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-17       Impact factor: 5.555

5.  Oligo/Amenorrhea Is an Independent Risk Factor Associated With Low Ovarian Response.

Authors:  Kai-Lun Hu; Kwanghann Gan; Yue Ying; Junyan Zheng; Ruixue Chen; Jinglei Xue; Yiqing Wu; Yifeng Liu; Yimin Zhu; Lanfeng Xing; Dan Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-09       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.